Detalhe da pesquisa
1.
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study.
Cancer
; 129(8): 1195-1204, 2023 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748723
2.
Novel treatment approaches for HER2 positive solid tumors (excluding breast cancer).
Curr Opin Oncol
; 34(5): 570-574, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943440
3.
Maintenance therapy and drug holiday in sarcoma patients: systematic review.
Acta Oncol
; 59(9): 1084-1090, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32400254
4.
Reappraisal of eligibility criteria in cancer clinical trials.
Curr Opin Oncol
; 30(5): 352-357, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30020120
5.
Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial.
BMC Cancer
; 18(1): 963, 2018 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30305054
6.
Diagnostic Value of the Texture Analysis Parameters of Retroperitoneal Residual Masses on Computed Tomographic Scan after Chemotherapy in Non-Seminomatous Germ Cell Tumors.
Cancers (Basel)
; 15(11)2023 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296963
7.
Taxanes Versus Androgen Receptor Therapy as Second-Line Treatment for Castrate-Resistant Metastatic Prostate Cancer After First-Line Androgen Receptor Therapy.
Clin Genitourin Cancer
; 21(3): 349-356.e2, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36935298
8.
Does bevacizumab increase joint pain in patients with cancer? Results of the prospective observational BEVARTHRALGIA study.
Cancer Chemother Pharmacol
; 87(4): 533-541, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33438069
9.
FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma.
Ther Adv Med Oncol
; 13: 17588359211029825, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34349842
10.
Anti-Angiogenic Agents in Management of Sarcoma Patients: Overview of Published Trials.
Front Oncol
; 10: 594445, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33330082
11.
Overview of « druggable ¼ alterations by histological subtypes of sarcomas and connective tissue intermediate malignancies.
Crit Rev Oncol Hematol
; 150: 102960, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32320927
12.
Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases.
Front Oncol
; 9: 732, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31448234
13.
Prognostic value of the texture analysis parameters of the initial computed tomographic scan for response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.
Radiother Oncol
; 135: 153-160, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31015162
14.
Re: Chemotherapy in patients with localized angiosarcoma of any site. A retrospective European study.
Eur J Cancer
; 175: 41-42, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087396
15.
A lesion suspected of being a desmoid tumor in the context of familial adenomatous polyposis should be biopsied.
Dig Liver Dis
; 54(10): 1446-1447, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705457
16.
[What biomarkers for the future? The point of view of the residents in oncology after the ESMO 2016 Congress]. / Quels biomarqueurs d'avenir ? Le point de vue des internes en oncologie à l'issue du congrès de l'ESMO 2016.
Bull Cancer
; 104(9): 744-751, 2017 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-28826736
17.
Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).
Eur J Cancer
; 79: 119-128, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28478340
18.
"TNM" at study entry in phase I trials.
Bull Cancer
; 108(6): 671-672, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33966884
19.
Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO).
Oncotarget
; 7(45): 73984-73994, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27659533
20.
Molecular targeted therapies in advanced or metastatic chordoma patients: facts and hypotheses.
Crit Rev Oncol Hematol
; 95(1): 125-31, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25682222